So, providers should evaluate these findings alongside those other considerations as they assess which option might be best for their individual patients. Rodriguez said their research group plans to examine more trends with semaglutide, tirzepatide and other medications in the future, including outcomes for treating other conditions, barriers to equitable access, health outcomes following medication discontinuation and trends for restarting a medication
Its a significant shift in how we approach healthcareone that prioritizes direct access and patient empowerment
Wegovy Compared to Ozempic and Other GLP-1 Agents Although Wegovy and Ozempic both contain semaglutide, Wegovy is specifically formulated and approved for weight loss, whereas Ozempic is indicated for diabetes treatment
Important safety information: Zepbound carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Authorities approved it with brand names: Ozempic, Rybelsus, and Wegovy
